#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5227706	B	Inhibition of human ASIC1a in HEK293 cells assessed as inward proton-gated current at pH 6.0 incubated with compound followed by PcTx1 addition by patch-clamp electrophysiology	Homo sapiens	11		cell-based format	Scientific Literature
2.	ALA5227707	B	Inhibition of mouse ASIC1a expressed in genetically engineered-CHO-K1 cells at 10 uM preincubated for 10 mins at pH 7.4 followed by cell stimulation with proton injection at pH 6.5 by electro-chromic fluorescence voltage sensor-based assay relative to control	Mus musculus	12		cell-based format	Scientific Literature
3.	ALA5227708	B	Inhibition of mouse ASIC2a expressed in genetically engineered-CHO-K1 cells at 10 uM preincubated for 10 mins at pH 7.4 followed by cell stimulation with proton injection at pH 6.5 by electro-chromic fluorescence voltage sensor-based assay relative to control	Mus musculus	12		cell-based format	Scientific Literature
4.	ALA5227709	B	Inhibition of ASIC1a in acid stimulated-human Neural Progenitor Cells assessed as reduction in current amplitude at pH 6.5 at 10 uM measured for 5 mins with acid stimulation for every 2 mins by electrophysiology relative to control	Homo sapiens	1		cell-based format	Scientific Literature
5.	ALA5227710	B	Inhibition of ASIC1a in acid stimulated-human Neural Progenitor Cells assessed as reduction in current amplitude at pH 6.5 at 10 uM measured for 5 mins with acid stimulation for every 2 mins by electrophysiology (Rvb = 92.41 +/- 33.66 pA)	Homo sapiens	1		cell-based format	Scientific Literature
6.	ALA5227716	F	Neuroprotective activity in OGD/Rx-induced E16 Wistar rat Primary cortical neurons assessed as increase in cell viability at 0.4 uM incubated for 3 hrs during OGD followed by reoxygenation with compound re-addition measured after 21 hrs by MTT assay	Rattus norvegicus	1		cell-based format	Scientific Literature
7.	ALA5227721	F	Neuroprotective activity in OGD/Rx-induced E16 Wistar rat Primary cortical neurons assessed as increase in cell viability at 0.4 uM incubated for 3 hrs during OGD followed by compound removal and reoxygenation measured after 21 hrs by MTT assay	Rattus norvegicus	1		cell-based format	Scientific Literature
8.	ALA5227727	F	Neuroprotective activity in OGD/Rx-induced E16 Wistar rat Primary cortical neurons assessed as increase in cell viability incubated for 3 hrs during OGD followed by reoxygenation with compound re-addition measured after 21 hrs by MTT assay	Rattus norvegicus	2		cell-based format	Scientific Literature
9.	ALA5227728	F	Neuroprotective activity in mouse model of middle cerebral artery occlusion-induced transient brain ischemia assessed as decrease in ischemic volume at 0.65 mg/kg, ip administered thrice measured after 24 hrs (Rvb = 58 +/- 2.6 %)	Mus musculus	1		organism-based format	Scientific Literature
10.	ALA5227731	F	Neuroprotective activity in mouse model of middle cerebral artery occlusion-induced transient brain ischemia assessed as reduction in general neurological deficits at 0.65 mg/kg, ip administered thrice measured after 24 hrs	Mus musculus	1		organism-based format	Scientific Literature
11.	ALA5227732	F	Neuroprotective activity in mouse model of middle cerebral artery occlusion-induced transient brain ischemia assessed as reduction in focal neurological deficits at 0.65 mg/kg, ip administered thrice measured after 24 hrs	Mus musculus	1		organism-based format	Scientific Literature
12.	ALA5227738	F	Neuroprotective activity in mouse model of middle cerebral artery occlusion-induced transient brain ischemia assessed as ischemic volume at 6.5 mg/kg, ip administered thrice measured after 24 hrs relative to control	Mus musculus	1		organism-based format	Scientific Literature
13.	ALA5227739	F	Neuroprotective activity in mouse model of middle cerebral artery occlusion-induced transient brain ischemia assessed as ischemic volume at 0.65 mg/kg, ip administered thrice measured after 24 hrs relative to control	Mus musculus	1		organism-based format	Scientific Literature
14.	ALA5227740	F	Neuroprotective activity in mouse model of middle cerebral artery occlusion-induced transient brain ischemia assessed as reduction in ischemic volume at 0.65 mg/kg, ip administered thrice measured upto 72 hrs relative to control	Mus musculus	1		organism-based format	Scientific Literature
15.	ALA5227741	F	Neuroprotective activity in mouse model of middle cerebral artery occlusion-induced transient brain ischemia assessed as reduction in general neurological deficits at 0.65 mg/kg, ip administered thrice measured upto 72 hrs	Mus musculus	1		organism-based format	Scientific Literature
16.	ALA5227742	F	Neuroprotective activity in mouse model of middle cerebral artery occlusion-induced transient brain ischemia assessed as reduction in focal neurological deficits at 0.65 mg/kg, ip administered thrice measured upto 72 hrs	Mus musculus	1		organism-based format	Scientific Literature